By expenditures
| Name | Title | Type |
|---|---|---|
| Lynn Lasof | Chief Financial Officer | Auditee |
| Carlos Rojas | CFO | Auditee |
| Bryce Rassilyer | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 414272 | 2025 | 2026-09-30 | CLIFTONLARSONALLEN LLP | $7.14M |
| 374734 | 2024 | 2025-12-15 | CLIFTONLARSONALLEN LLP | $6.85M |
| 321877 | 2023 | 2024-09-27 | Cliftonlarsonallen LLP | $5.76M |
| 294734 | 2022 | 2024-03-12 | Cliftonlarsonallen LLP | $6.89M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 414272 | 2025 | 2026-09-30 | 1239559 | 2025-007 | Material Weakness | Yes | A |
| 414272 | 2025 | 2026-09-30 | 1239558 | 2025-007 | Material Weakness | Yes | A |
| 414272 | 2025 | 2026-09-30 | 1239557 | 2025-006 | Material Weakness | Yes | AB |
| 414272 | 2025 | 2026-09-30 | 1239556 | 2025-006 | Material Weakness | Yes | AB |
| 414272 | 2025 | 2026-09-30 | 1239555 | 2025-006 | Material Weakness | Yes | AB |
| 414272 | 2025 | 2026-09-30 | 1239554 | 2025-005 | Material Weakness | Yes | AB |
| 414272 | 2025 | 2026-09-30 | 1239553 | 2025-005 | Material Weakness | Yes | AB |
| 414272 | 2025 | 2026-09-30 | 1239552 | 2025-004 | Material Weakness | Yes | J |
| 414272 | 2025 | 2026-09-30 | 1239551 | 2025-004 | Material Weakness | Yes | J |
| 414272 | 2025 | 2026-09-30 | 1239550 | 2025-003 | Material Weakness | Yes | I |
| 414272 | 2025 | 2026-09-30 | 1239549 | 2025-003 | Material Weakness | Yes | I |
| 414272 | 2025 | 2026-09-30 | 1239548 | 2025-003 | Material Weakness | Yes | I |
| 321877 | 2023 | 2024-09-27 | 1075533 | 2023-003 | Significant Deficiency | - | AB |
| 321877 | 2023 | 2024-09-27 | 1075532 | 2023-003 | Significant Deficiency | - | AB |
| 321877 | 2023 | 2024-09-27 | 1075531 | 2023-002 | Significant Deficiency | - | L |
| 321877 | 2023 | 2024-09-27 | 1075530 | 2023-003 | Significant Deficiency | - | AB |
| 321877 | 2023 | 2024-09-27 | 1075529 | 2023-003 | Significant Deficiency | - | AB |
| 321877 | 2023 | 2024-09-27 | 1075528 | 2023-002 | Significant Deficiency | - | L |
| 321877 | 2023 | 2024-09-27 | 499091 | 2023-003 | Significant Deficiency | - | AB |
| 321877 | 2023 | 2024-09-27 | 499090 | 2023-003 | Significant Deficiency | - | AB |
| 321877 | 2023 | 2024-09-27 | 499089 | 2023-002 | Significant Deficiency | - | L |
| 321877 | 2023 | 2024-09-27 | 499088 | 2023-003 | Significant Deficiency | - | AB |
| 321877 | 2023 | 2024-09-27 | 499087 | 2023-003 | Significant Deficiency | - | AB |
| 321877 | 2023 | 2024-09-27 | 499086 | 2023-002 | Significant Deficiency | - | L |
| 294734 | 2022 | 2024-03-12 | 952100 | 2022-003 | Significant Deficiency | - | B |
| 294734 | 2022 | 2024-03-12 | 375658 | 2022-003 | Significant Deficiency | - | B |